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Abstract 
We present a new, handheld system for in vivo detection of radiotracers. The detection is based on scintillators cou-
pled to Silicon Photomultipliers (SiPMs) and aimed at direct positron detection. The battery-powered system is wire-
lessly connected to a PC. A graphical user interface allows controlling the probe functions and monitoring count 
rates, battery voltage and temperature. The probe is fully compatible with standard sterilisation procedures and has 
been successfully used in pre-clinical trials with human cancer patients. The use of the probe requires that the patient 
be administered a dose of the radiopharmaceutical 18F-fluorodeoxyglucose (FDG), a ȕ+ emitting glucose analogue 
used for detecting tumours in oncology, which can still be detected during the operation. 
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1.Introduction 
During the last decades, positron emission tomography (PET) has been established as the imaging 
technique of choice to indentify and localise tumours and metastases prior to surgical interventions. PET 
images localise the tumour in 3D at the time of the scan, while it does not provide an updated fix of tu-
mours and metastases at actual the time of the surgical intervention. However, organs in the human body 
move continuously, so any PET image recorded before the operation is outdated quickly and can only 
 
* Corresponding author. Tel.: +41ௗ21ௗ693ௗ75ௗ28; fax: +41ௗ21ௗ693ௗ52ௗ63. 
E-mail address: christian.mester@epfl.ch. 
Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.
989C. Mester et al. / Procedia Engineering 25 (2011) 988 – 991
give approximate information on the location of tumours and metastases at the time of the operation. Ac-
quisition of PET images during a surgical intervention is impossible, due to the size of the hypothetical 
machine that could achieve such functionality. To address this problem, we propose a handheld sensor 
system that is small enough to be used during operations [1] and this is sensitive to the same, well-known 
radiopharmaceutical as PET scanners [2]. With our sensor system, the surgeon can intra-operatively pre-
cisely localise the tumours and metastases already identified in previous PET scans and choose the resec-
tion margins based on measurements taken seconds before the resection. After resection, it is possible to 
verify the margins and, if needed, remove residuals during the very same intervention. Therefore, our sys-
tem allows to considerably increase an intervention’s probability of success, which largely depends on 
accurately finding neoplastic lymph nodes and metastatic tissues, and on properly choosing the resection 
margins. 
This paper describes the target application and explains the need for such a sensor system before giving 
information on the implementation and the clinical use. 
2.Target application 
The handheld sensor is optimised for direct positron detection. The radiopharmaceutical emits ȕ+ parti-
cles (positrons). ȕ+ particles have a short range in matter and annihilate with electrons, producing two 
back-to-back Ȗ rays with energies of 511 keV each. PET scanners detect these Ȗ rays, which have a long 
range and can pass through the patient with little attenuation. This allows for the generation of a tomo-
graphic image, allowing diagnosis and coarse localisation of tumours and metastases and preparing a sur-
gical intervention. The aim of the presented probe is different; it is to be used during a surgical interven-
tion searching to remove tumours and/or metastases previously diagnosed with e.g. a PET scan. For this, 
it is important to have a small, easy to use device with high spatial resolution. 511 keV Ȗ rays can traverse 
the whole body of the patient, i.e. at any chosen point in or close to the patient, Ȗ rays from all over the 
body can be detected. As the area studied in detail is very small compared to the whole body, the back-
ground signals are dominating. ȕ+ particles in turn have a range in tissue and air in the order of millime-
tres or tens of millimetres, so when ȕ+ particles are detected, their source is close to the sensor. A long 
range is not required, as the surgeon knows the approximate position of the target, and not desired, be-
cause the place of the detector would, without additional tools such as collimators, give only little infor-
mation on the place of the source of radiation. 
3.Implementation 
3.1.Detection 
The detector is composed of a scintillator and a silicon photomultiplier (SiPM). The thickness of the 
scintillator has been chosen to maximise the ratio of the detection probability for ȕ+, the desired signal, 
divided by the detection probability for Ȗ, the background-dominated signal. Our simulations show that 
the detection probability for ȕ+ in a scintillator of more than 1 mm thickness is proportional to the surface 
of cross section of the scintillator, while the detection probability for 511 keV Ȗ is proportional to the vol-
ume of the scintillator. 
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Positrons hitting the scintillator generate photons, mainly through Compton scattering, which are de-
tected by the SiPM with a probability depending on the SiPM, the environment conditions and the SiPM 
bias voltage. When increasing the bias voltage, not only the detection probability increases, but also the 
dark count rate, i.e. the rate at which a signal is generated in the SiPM even though no photon has been 
detected. To reduce the dark count rate, we use two independent SiPMs in coincidence mode [3]. Dark 
counts are not correlated between the two SiPMs, while photons in the scintillator are detected by both 
SiPM and thus generate a signal in both SiPMs. Rejecting dark counts allows for setting the operating 
point of the detector in a regime of 1000-times higher sensitivity while keeping the dark counts after fil-
tering at rates smaller than 1/s. 
Fig. 1: Block diagram of the handheld part of the sensor system 
3.2.Signal processing, Slow Control and User Interface 
Fig. 1 shows the block diagram of the handheld part of the sensor system. The output signals of the 
SiPMs are amplified, shaped and discriminated by custom designed electronics. The discrimination 
threshold is set to the equivalent of 4 photo-electrons. The pulses in the individual SiPM channels are 
counted. A pulse in one channel opens a gate window in the respective other channel. If a pulse arrives 
within this window, the pair of events is counted as one coincidence event. The counters are read by a 
microcontroller and sent to the control PC via a BlueTooth link. The microcontroller sends temperature 
and battery voltage measurements to the PC and sets the SiPM bias voltages and discriminator thresholds 
at the PC’s request. 
The PC is used for slow control and as user interface. All measurements are sent to the PC without any 
digital filtering other than the coincidence filtering. Using a probe-specific calibration file, the PC calcu-
lates the optimum bias voltages at the given temperature and configures the probe accordingly. This not 
only reduces the impact analogue component tolerances and environment dependencies, but also allows 
for extensive data logging for later analysis. 
4.Clinical Use 
The fully sterilisable sensor system has been successful in a number of operations involving metastatic 
lymph nodes. Two versions of the probe have been developed; one with a 44 mm long tip for operations 
with large incisions and easily accessible regions of interest, and one with a 250 mm long tip for laparo-
scopic interventions. For both probes, the tip has an outer diameter of 9 mm and contains the scintillator 
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and the photomultipliers. The end parts with a diameter of 22 mm are identical for both versions and con-
tain the electronics, including the BlueTooth transceiver, and batteries. The surgeon holds the probe at the 
wide part like a white-board marker pen. 
Fig. 2 shows resected tissue being studied in the operating theatre, right next to the patient, in an early 
clinical trial. Our probe has been used successfully to ensure complete resection of a tumour. 
Fig. 2: Early clinical trial: Studying resected tissue in the operating theatre. 
5.Summary 
We have presented a handheld, ȕ+ sensitive, wireless and fully sterilisable sensor system prototype for 
intra-operative use. The sensor has been successfully used in a number of pilot pre-clinical trials. The use 
of two Silicon Photomultipliers (SiPMs) in coincidence mode has allowed for an increased sensitivity 
while keeping the dark count rate below 1/s. 
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